AWM
RMD icon

Angeles Wealth Management’s ResMed RMD Stock Holding History

Angeles Wealth Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,204
Closed -$270K – 649
2026
Q1 		$270K Sell
1,204
-12
-1% -$2.99K 0.01% 347
2025
Q4 		$293K Buy
1,216
+3
+0.2% +$767 0.02% 298
2025
Q3 		$332K Sell
1,213
-97
-7% -$26.5K 0.02% 243
2025
Q2 		$338K Buy
1,310
+128
+11% +$30.5K 0.02% 239
2025
Q1 		$265K Buy
1,182
+59
+5% +$13.8K 0.02% 244
2024
Q4 		$257K Hold
1,123
– – 0.02% 245
2024
Q3 		$274K Buy
+1,123
New +$251K 0.02% 219

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Angeles Wealth Management's RMD Position: Q2 2026 in Review

Angeles Wealth Management sold out of ResMed (RMD) in Q2 2026, closing a stake of 1,204 shares — an estimated $270K sold.

Angeles Wealth Management first reported a position in RMD in Q3 2024 and held it in 7 quarters. The position peaked at $338K in Q2 2025. 880 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Angeles Wealth Management reported no remaining ResMed position as of Q2 2026 after selling out during the quarter.
  • Angeles Wealth Management sold 1,204 ResMed shares in Q2 2026, an estimated $270K.
  • Angeles Wealth Management first reported a position in ResMed in Q3 2024 and held it in 7 quarters.
  • Angeles Wealth Management's ResMed position peaked at $338K in Q2 2025.
  • 880 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Angeles Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.